Clinical trials recruiting for Multiple Sclerosis, Secondary Progressive
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 0.9% Chloride Injection Sodium | 1 |
| Cladribine Subcutaneous Injection | 1 |
| KYV-101 anti-CD19 CAR-T cell therapy | 1 |
| Standard lymphodepletion regimen | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Illinois | 2 |
Top cities
Self-screener
Recruiting trials
- A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
- Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
- Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
- Intermittent Hypoxia in Persons With Multiple Sclerosis
- MS-ResearchBiomarkerS
Related conditions
Trials recruiting for Multiple Sclerosis, Secondary Progressive often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Multiple Sclerosis, Secondary Progressive trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.